Novo Nordisk A\/S NYSE NVO
$111.24 -0.40 -0.36%
Today share price
Denmark
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Показатель: 39 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

253.99B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

266.61B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.28
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

2.28B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

-0.68 %
Upcoming events Novo Nordisk A\/S All events
No upcoming events scheduled

Stock chart Novo Nordisk A\/S

Stock analysis Novo Nordisk A\/S

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
5.15 19.11
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
3.59 4.97
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
3.86 13.15
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.18 1.34
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
74.15 30.95

Price change Novo Nordisk A\/S per year

61.99$ 107.24$
Min Max

Summary analysis Novo Nordisk A\/S

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Novo Nordisk A\/S

Revenue and net income Novo Nordisk A\/S

All parameters
Stock news Novo Nordisk A\/S All news

About company Novo Nordisk A\/S

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Address:
Novo Allé 1, Bagsvaerd, Denmark, 2880
Company name: Novo Nordisk A\/S
Issuer ticker: NVO
ISIN: US6701002056
Country: Denmark
Exchange: NYSE
Currency: $
IPO date: 1982-01-04
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.novonordisk.com

On which stock exchange are Novo Nordisk A\/S (NVO) stocks traded?

Novo Nordisk A\/S (NVO) stocks are traded on NYSE.

What is the ticker of Novo Nordisk A\/S stocks (NVO)?

The stock ticker of Novo Nordisk A\/S’s stocks or in other words, the code is NVO. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Novo Nordisk A\/S (NVO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Novo Nordisk A\/S (NVO) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Novo Nordisk A\/S (NVO) stocks traded?

Novo Nordisk A\/S (NVO) stocks are traded on the NYSE exchange in dollars.

What is the price of Novo Nordisk A\/S (NVO) stocks today?

The current price of Novo Nordisk A\/S stocks on 06.07.2022 is 111.24 dollars. per share.

What is the dynamics of Novo Nordisk A\/S (NVO) stocks from the beginning of the year?

Novo Nordisk A\/S (NVO) quotes have increased by 0% from the beginning of the year up to 111.24 dollars. per 1 stocks.

How much did Novo Nordisk A\/S (NVO) stocks increase in июле 2022?

This month Novo Nordisk A\/S (NVO) quotes have increased by -0.36% to 111.24 dollars. per share.

How much are Novo Nordisk A\/S (NVO) stocks worth?

Today, on October, 06.07.2022 Novo Nordisk A\/S’s (NVO) stocks cost 111.24 dollars..

What is the market capitalization of Novo Nordisk A\/S (NVO)?

Capitalization is the market value of Novo Nordisk A\/S (NVO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 06.07.2022, the market capitalization of Novo Nordisk A\/S (NVO) is estimated at about 253994292000 dollars.